Skip to content

Clinical trials

Macular Degeneration trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Country / region: China Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20102
20113
20131
20152
20163
20173
20185
20193
20201
20213
20223
20233
20244
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status13
Recruiting9
Not yet recruiting4
Active, not recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Chengdu Kanghong Biotech Co., Ltd.3
Shanghai Henlius Biotech3
The First Affiliated Hospital with Nanjing Medical University3
AnewPharma2
Beijing Tongren Hospital2
Bio-Thera Solutions2
Chengdu Origen Biotechnology Co., Ltd.2
Innostellar Biotherapeutics Co.,Ltd2
Peking University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration48
Choroidal Neovascularization5
Geographic Atrophy5
Diabetic Retinopathy4
Retinal Vein Occlusion4
Vision Disorders4
Wet Macular Degeneration3
Myopia, Degenerative2
Polypoidal Choroidal Vasculopathy2
Retinal Diseases2

Trials

Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.